BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18798789)

  • 1. Recombinant human thyrotropin administration enhances thyroid uptake of radioactive iodine in hyperthyroid cats.
    van Hoek I; Daminet S; Vandermeulen E; Dobbeleir A; Duchateau L; Peremans K
    J Vet Intern Med; 2008; 22(6):1340-4. PubMed ID: 18798789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
    Huysmans DA; Nieuwlaat WA; Erdtsieck RJ; Schellekens AP; Bus JW; Bravenboer B; Hermus AR
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
    Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human TSH on the uptake of radioactive iodine ((123)I) by the thyroid gland in healthy beagles.
    Campos M; Peremans K; Duchateau L; Dobbeleir A; Vandermeulen E; van Hoek I; Paes G; Daminet S
    Domest Anim Endocrinol; 2010 Nov; 39(4):215-21. PubMed ID: 20688462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of recombinant human tsh on the thyroid (123)i uptake in iodide treated normal subjects.
    Lawrence JE; Emerson CH; Sullaway SL; Braverman LE
    J Clin Endocrinol Metab; 2001 Jan; 86(1):437-40. PubMed ID: 11232037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.
    Braverman L; Kloos RT; Law B; Kipnes M; Dionne M; Magner J
    Endocr Pract; 2008 Oct; 14(7):832-9. PubMed ID: 18996810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human thyrotropin stimulation prior to
    Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
    Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
    J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
    Nieuwlaat WA; Huysmans DA; van den Bosch HC; Sweep CG; Ross HA; Corstens FH; Hermus AR
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3121-9. PubMed ID: 12843153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects.
    Torres MS; Ramirez L; Simkin PH; Braverman LE; Emerson CH
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1660-4. PubMed ID: 11297600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human thyrotropin on the uptake of radioactive iodine (¹²³I) in dogs with thyroid tumors.
    Campos M; Peremans K; Vandermeulen E; Duchateau L; Bosmans T; Polis I; Daminet S
    PLoS One; 2012; 7(11):e50344. PubMed ID: 23209716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioactive iodine uptake in hyperthyroid cats after administration of recombinant human thyroid stimulating hormone.
    Oberstadt AE; Nelson NC; Claude AK; Refsal KR; Scott-Moncrieff JC; Petroff BK; Langlois DK
    J Vet Intern Med; 2018 Nov; 32(6):1891-1896. PubMed ID: 30315668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant human TSH on 123I thyroid uptake after intravenous iodide contrast agent.
    Resende M; Corbo R; Vaisman M
    Nucl Med Commun; 2010 Apr; 31(4):315-9. PubMed ID: 20087238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of iohexol with radioiodine thyroid uptake in the hyperthyroid cat.
    Peremans K; Vandermeulen E; van Hoek I; Daminet S; Vermeire S; Bacher K
    J Feline Med Surg; 2008 Oct; 10(5):460-5. PubMed ID: 18511320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.
    Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Veje A; Hegedüs L
    J Clin Endocrinol Metab; 2005 Jan; 90(1):79-83. PubMed ID: 15494456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrotropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic multinodular goiter.
    Duick DS; Baskin HJ
    Endocr Pract; 2004; 10(3):253-60. PubMed ID: 15310544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.
    Nieuwlaat WA; Hermus AR; Sivro-Prndelj F; Corstens FH; Huysmans DA
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5330-6. PubMed ID: 11701700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.